Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion.
Sekulic A, Liang WS, Tembe W, Izatt T, Kruglyak S, Kiefer JA, Cuyugan L, Zismann V, Legendre C, Pittelkow MR, Gohmann JJ, De Castro FR, Trent J, Carpten J, Craig DW, McDaniel TK.
Sekulic A, et al. Among authors: pittelkow mr.
Mol Genet Genomic Med. 2015 Mar;3(2):130-6. doi: 10.1002/mgg3.121. Epub 2014 Nov 27.
Mol Genet Genomic Med. 2015.
PMID: 25802883
Free PMC article.